Literature DB >> 1526060

Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat.

P H Falckh1, L A Harkin, R J Head.   

Abstract

1. In order to explore the mechanisms responsible for the hypernoradrenergic innervation of the vasculature in the spontaneously hypertensive rat (SHR) the tissue content of nerve growth factor messenger ribonucleic acid (NGFmRNA) was examined. 2. The concentration of NGFmRNA was markedly elevated in mesenteric veins obtained from SHR when compared with the contents of NGFmRNA in veins from Wistar Kyoto rats (WKY). 3. The NGFmRNA content of kidneys was greater in SHR when compared with the levels present in WKY rats for 10- and 43-day-old animals. 4. In contrast to the pattern observed for veins and kidneys, the NGFmRNA content of SHR hearts was smaller than those present in hearts from WKY rats for 2, 10 and 43-day-old animals. 5. The results demonstrate that tissues with enhanced innervation (the kidney and mesenteric vasculature) in SHR are associated with an enhanced expression of NGFmRNA. In contrast, the heart, which does not display an enhanced sympathetic innervation in the SHR, does not have an increased expression of NGFmRNA. 6. It is suggested that in the SHR there is a tight relationship between hypernoradrenergic innervation in the vasculature and gene expression for NGFmRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526060     DOI: 10.1111/j.1440-1681.1992.tb00502.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Absence of the p75 neurotrophin receptor alters the pattern of sympathosensory sprouting in the trigeminal ganglia of mice overexpressing nerve growth factor.

Authors:  G S Walsh; K M Krol; M D Kawaja
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

2.  Plasma and Urinary Levels of Nerve Growth Factor Are Elevated in Primary Hypertension.

Authors:  Fumihiro Tomoda; Atsumi Nitta; Hiroko Sugimori; Tsutomu Koike; Koichiro Kinugawa
Journal:  Int J Hypertens       Date:  2022-03-01       Impact factor: 2.420

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.